Adverse Neuropsychiatric Events Associated with Varenicline: A Case Series
Varenicline is an orally administered α4β2 nicotinic acetylcholine (Ach) receptor, partial agonist. This drug has been known to be more effective in the treatment of nicotine withdrawal than bupropion and nicotine replacement therapies. Besides this effectiveness, it has some systemic and...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Psychopharmacology Association
2021-03-01
|
| Schriftenreihe: | Psychiatry and Behavioral Sciences |
| Schlagworte: | |
| Online-Zugang: | http://www.ejmanager.com/fulltextpdf.php?mno=302645354 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|